These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19501715)

  • 1. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.
    Griffith HR; Stewart CC; den Hollander JA
    Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
    Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
    Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in Alzheimer's disease, a review.
    Loos C; Achten E; Santens P
    Acta Neurol Belg; 2010 Dec; 110(4):291-8. PubMed ID: 21305856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment.
    Dickerson BC
    Curr Opin Psychiatry; 2006 May; 19(3):299-306. PubMed ID: 16612217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of 1H MR spectroscopy findings in Alzheimer's disease.
    Soher BJ; Doraiswamy PM; Charles HC
    Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy in cognitive research.
    Ross AJ; Sachdev PS
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):83-102. PubMed ID: 15003387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait in ageing and associated dementias; its relationship with cognition.
    Scherder E; Eggermont L; Swaab D; van Heuvelen M; Kamsma Y; de Greef M; van Wijck R; Mulder T
    Neurosci Biobehav Rev; 2007; 31(4):485-97. PubMed ID: 17306372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Proton magnetic resonance spectroscopy in the evaluation of cognitive disturbances].
    Mathiesen HK; Nielsen AS; Nielsen K; Hanson LG
    Ugeskr Laeger; 2006 Jan; 168(4):357-9. PubMed ID: 16436234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dementia: a brief review.
    Grossman H; Bergmann C; Parker S
    Mt Sinai J Med; 2006 Nov; 73(7):985-92. PubMed ID: 17195884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy in common dementias.
    Kantarci K
    Neuroimaging Clin N Am; 2013 Aug; 23(3):393-406. PubMed ID: 23928196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson-related dementias.
    Boeve BF
    Neurol Clin; 2007 Aug; 25(3):761-81, vii. PubMed ID: 17659189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Magnetic Resonance Spectroscopy in Common Dementias-Current Status and Perspectives.
    Maul S; Giegling I; Rujescu D
    Front Psychiatry; 2020; 11():769. PubMed ID: 32848938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of cognitive dysfunction.
    Tayebati SK
    Mech Ageing Dev; 2006 Feb; 127(2):100-8. PubMed ID: 16293295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-surgical potentially reversible dementias].
    Santos-Franco JA; Barquet-Platón EI; Mercado-Pimentel R; Ortiz-Velázquez RI; Cardona-Cabrera S; Otero-Siliceo E
    Rev Neurol; 2005 Jan 1-15; 40(1):54-60. PubMed ID: 15696427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.